Zhitong Finance App News, Yinnuo Pharmaceutical-B (02591.HK) issued an announcement. The board of directors of the Company has received Dr. Wang Qinghua (Dr. Wang), founder of the Group, Chairman, Executive Director, General Manager and major shareholder of the Company; Executive Director, Hong Kong Yiyun Pharmaceutical Technology Co., Ltd. shareholder and limited partner of the Company's employee incentive platform Guangzhou Nopa Enterprise Management Partnership (Limited Partnership) (Guangzhou Nopa); and Ms. Xu Jiewen (Ms. Xu), executive director and executive partner of Guangzhou Nopa; Mr. Huang Bing (Mr. Huang), director and limited partner of Guangzhou Nopa, advised:

Zhitong Finance App News, Yinnuo Pharmaceutical-B (02591.HK) issued an announcement. The board of directors of the Company has received Dr. Wang Qinghua (Dr. Wang), founder of the Group, Chairman, Executive Director, General Manager and major shareholder of the Company; Executive Director, Hong Kong Yiyun Pharmaceutical Technology Co., Ltd. shareholder and limited partner of the Company's employee incentive platform Guangzhou Nopa Enterprise Management Partnership (Limited Partnership) (Guangzhou Nopa); and Ms. Xu Jiewen (Ms. Xu), executive director and executive partner of Guangzhou Nopa; Mr. Huang Bing (Mr. Huang), director and limited partner of Guangzhou Nopa, advised: